AI assistant
Sending…
Medistim — Earnings Release 2013
Feb 20, 2014
3662_rns_2014-02-20_ce96d3bb-13df-4e8c-8b9c-31b04e1db3fd.html
Earnings Release
Open in viewerOpens in your device viewer
4th quarter and preliminary year end financials for 2013 for Medistim ASA
4th quarter and preliminary year end financials for 2013 for Medistim ASA
Medistim delivers record sales for a quarter with
MNOK 52.2 (MNOK 49.7). Sales for 2013 ended at MNOK
191 (MNOK 183.8), which is a 3.9 % growth. Operating
profit (EBIT) for the quarter ended at MNOK 9.0 (MNOK
6.1). Operating profit for 2013 ended at MNOK 35.6
(MNOK 41.1). The Board suggests a dividend of NOK
0.80 per share (MNOK 1.10).
More from Medistim
Major Shareholding Notification
2026
May 12
Major Shareholding Notification
2026
May 12
Notice of Dividend Amount
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 6
Notice of Dividend Amount
2026
May 6
Notice of Dividend Amount
2026
Apr 30
Report Publication Announcement
2026
Apr 28